Cargando…

Nanomedicinal products: a survey on specific toxicity and side effects

Due to their specific properties and pharmacokinetics, nanomedicinal products (NMPs) may present different toxicity and side effects compared to non-nanoformulated, conventional medicines. To facilitate the safety assessment of NMPs, we aimed to gain insight into toxic effects specific for NMPs by s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brand, Walter, Noorlander, Cornelle W, Giannakou, Christina, De Jong, Wim H, Kooi, Myrna W, Park, Margriet VDZ, Vandebriel, Rob J, Bosselaers, Irene EM, Scholl, Joep HG, Geertsma, Robert E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574663/ https://www.ncbi.nlm.nih.gov/pubmed/28883724 http://dx.doi.org/10.2147/IJN.S139687

Ejemplares similares

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou, Christina, et al.
Publicado: (2016)

Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls
por: Giannakou, Christina, et al.
Publicado: (2020)

An inter-laboratory comparison of an NLRP3 inflammasome activation assay and dendritic cell maturation assay using a nanostructured lipid carrier and a polymeric nanomedicine, as exemplars
por: Vandebriel, Rob J., et al.
Publicado: (2022)

Physicochemical characteristics of nanomaterials that affect pulmonary inflammation
por: Braakhuis, Hedwig M, et al.
Publicado: (2014)

Safe-and-Sustainable-by-Design Framework Based on a Prospective Life Cycle Assessment: Lessons Learned from a Nano-Titanium Dioxide Case Study
por: Tsalidis, Georgios Archimidis, et al.
Publicado: (2022)

Transcriptomic Analysis in Human 3D Skin Model Injected with Resorbable Hyaluronic Acid Fillers Reveals Foreign Body Response
por: Jennen, Danyel G. J., et al.
Publicado: (2022)

Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities
por: Noorlander, Cornelle W., et al.
Publicado: (2008)

Correction: Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities
por: Noorlander, Cornelle W., et al.
Publicado: (2009)

Life cycle thinking and safe-and-sustainable-by-design approaches for the battery innovation landscape
por: Soeteman-Hernández, Lya G., et al.
Publicado: (2023)

Different biokinetics of nanomedicines linking to their toxicity; an overview
por: Mostafalou, Sara, et al.
Publicado: (2013)

Antenatal Glucocorticoid Treatment Affects Hippocampal Development in Mice
por: Noorlander, Cornelle W., et al.
Publicado: (2014)

In Vitro and In Vivo Models for Evaluating the Oral Toxicity of Nanomedicines
por: Lama, Sudeep, et al.
Publicado: (2020)

Chemotherapeutic-caused liver toxicity hinders nanomedicine development
por: Wu, Pengfei, et al.
Publicado: (2023)

Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats
por: Vandebriel, Rob J, et al.
Publicado: (2014)

Bridging communities in the field of nanomedicine
por: Halamoda-Kenzaoui, Blanka, et al.
Publicado: (2019)

Nanomedicine
por: Howard, Kenneth A, et al.
Publicado: (2016)

A new species of Heser Tuneva, 2005 (Araneae, Gnaphosidae) from the south of India
por: Bosselaers, Jan
Publicado: (2010)

Evaluation of Adverse Effects of Resorbable Hyaluronic Acid Fillers: Determination of Macrophage Responses
por: De Jong, Wim H., et al.
Publicado: (2022)

A Decision Support System for preclinical assessment of nanomaterials in medical products: the REFINE DSS
por: Zabeo, Alex, et al.
Publicado: (2022)

Nanomedicines for the Delivery of Biologics
por: Wahlich, John, et al.
Publicado: (2019)

Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine
por: Damasco, Jossana A., et al.
Publicado: (2020)

Use of Physiologically Based Kinetic Modeling-Facilitated Reverse Dosimetry to Predict In Vivo Acute Toxicity of Tetrodotoxin in Rodents
por: Noorlander, Annelies, et al.
Publicado: (2022)

Tackling the challenges of nanomedicines: are we ready?
por: Hertig, John B, et al.
Publicado: (2021)

Presentation PICASSO for COPD: a Dutch national COPD optimisation platform
por: Noorlander, Therese
Publicado: (2008)

The handbook of nanomedicine
por: Jain, Kewal K
Publicado: (2017)

Principles of nanomedicine
por: Bhattacharjee, Sourav
Publicado: (2019)

The era of nanomedicine
por: Grenha, Ana
Publicado: (2011)

Bionanotechnology and Nanomedicine
por: Chase, P. Bryant, et al.
Publicado: (2012)

Handbook of nanomedicine
por: Jain, Kewal K
Publicado: (2012)

Fucoidans in Nanomedicine
por: Chollet, Lucas, et al.
Publicado: (2016)

Introduction to Nanomedicine
por: Astruc, Didier
Publicado: (2015)

Cancer Nanomedicine
por: Hoskins, Clare
Publicado: (2020)

The consolidation of nanomedicine
por: Zingg, Raphael, et al.
Publicado: (2019)

Heterojunction Nanomedicine
por: Pan, Chao, et al.
Publicado: (2022)

Ocular Nanomedicine
por: Tang, Zhimin, et al.
Publicado: (2022)

Cancer nanomedicine
por: Bhatia, Sangeeta N., et al.
Publicado: (2022)

Tumour-targeted nanomedicines: principles and practice
por: Lammers, T, et al.
Publicado: (2008)

Diverse Applications of Nanomedicine
por: Pelaz, Beatriz, et al.
Publicado: (2017)

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

Time to onset in statistical signal detection revisited: A follow‐up study in long‐term onset adverse drug reactions
por: Scholl, Joep H.G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_97snr4ai0itbub94esp9ejotvh